nivolumab,brentuximab vedotin
bms,seagen
['brentuximab', 'nivo', ' vedo', 'lymsm', 'nivolumab']
interesting study schema for the accru-ly1601 trial of a+avd followed by pet-adapted nivolumab or brentuximab vedotin-nivo #ash22 #lymsm questions about ?overtreatment of the pet-negative arm &amp; choice of 8 cycles of nivolumab - selection of 8 cycles 'arbitrary' per dr park 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer